• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aytu BioPharma, Inc. - Common Stock (NQ:AYTU)

2.770 +0.170 (+6.54%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 181,562
Open 2.560
Bid (Size) 2.200 (200)
Ask (Size) 2.820 (100)
Prev. Close 2.600
Today's Range 2.560 - 2.790
52wk Range 0.9500 - 2.820
Shares Outstanding 5,567,490
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Aytu BioPharma to Host Investor Day on January 20, 2026 in New York City
December 18, 2025
Via ACCESS Newswire
News headline image
Aytu BioPharma Announces Commercial Availability of EXXUA(TM) (gepirone) Extended-Release Tablets, the First and Only 5HT1a Agonist Indicated for the Treatment of Major Depressive Disorder in Adults
December 15, 2025
Via ACCESS Newswire

Performance

YTD
N/A
N/A
1 Month
+23.7%
+23.7%
3 Month
+26.5%
+26.5%
6 Month
+17.9%
+17.9%
1 Year
+56.1%
+56.1%

More News

Read More
News headline image
Aytu BioPharma to Participate in Noble Capital Markets 21st Annual Emerging Growth Equity Conference
November 24, 2025
Via ACCESS Newswire
News headline image
Aytu BioPharma Inc (NASDAQ:AYTU) Reports Q1 2026 Revenue Beat and Progress on EXXUA Launch ↗
November 13, 2025
Via Chartmill
News headline image
Aytu BioPharma Reports Fiscal 2026 First Quarter Operational and Financial Results
November 13, 2025
Via ACCESS Newswire
News headline image
Earnings Scheduled For November 13, 2025 ↗
November 13, 2025
Via Benzinga
News headline image
Insights into Aytu BioPharma's Upcoming Earnings ↗
November 12, 2025
Via Benzinga
News headline image
Aytu BioPharma to Report Fiscal 2026 First Quarter Operational and Financial Results on November 13, 2025
November 05, 2025
Via ACCESS Newswire
News headline image
Aytu BioPharma Announces Patent Term Extension for EXXUA(TM)
October 28, 2025
Via ACCESS Newswire
News headline image
Aytu BioPharma to Present at Upcoming October 2025 Conferences
October 10, 2025
Via ACCESS Newswire
News headline image
11 Company Presentations Today at The MicroCap Rodeo Conference
September 25, 2025
Via ACCESS Newswire
News headline image
Aytu BioPharma to Present at Upcoming September 2025 Conferences
September 24, 2025
Via ACCESS Newswire
News headline image
Top movers in Wednesday's session ↗
September 24, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
September 24, 2025
Via Benzinga
News headline image
Keep an eye on the top gainers and losers in Wednesday's session. ↗
September 24, 2025
Via Chartmill
News headline image
Gapping stocks in Wednesday's session ↗
September 24, 2025
Via Chartmill
News headline image
Get insights into the top gainers and losers of Wednesday's pre-market session. ↗
September 24, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
September 24, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
September 23, 2025
Via Benzinga
News headline image
What's going on in today's after hours session ↗
September 23, 2025
Via Chartmill
News headline image
Aytu BioPharma Inc (NASDAQ:AYTU) Shares Fall on Q4 Revenue and EPS Miss ↗
September 23, 2025
Via Chartmill
News headline image
Aytu BioPharma Reports Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results and Outlines Commercial Launch Plans for EXXUA(TM)
September 23, 2025
Via ACCESS Newswire
News headline image
Aytu BioPharma's Q4 2025 Earnings: Anticipation Mounts Ahead of Key EXXUA Launch
September 23, 2025
Via MarketMinute
Topics Earnings
Dow Futures Gain Ahead Of Jerome Powell’s Speech: BA, HOLO, BETR, CLSK Among Stocks To Watch ↗
September 23, 2025
Via Stocktwits
Topics Economy Stocks
News headline image
Earnings Scheduled For September 23, 2025 ↗
September 23, 2025
Via Benzinga

Frequently Asked Questions

Is Aytu BioPharma, Inc. - Common Stock publicly traded?
Yes, Aytu BioPharma, Inc. - Common Stock is publicly traded.
What exchange does Aytu BioPharma, Inc. - Common Stock trade on?
Aytu BioPharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Aytu BioPharma, Inc. - Common Stock?
The ticker symbol for Aytu BioPharma, Inc. - Common Stock is AYTU on the Nasdaq Stock Market
What is the current price of Aytu BioPharma, Inc. - Common Stock?
The current price of Aytu BioPharma, Inc. - Common Stock is 2.770
When was Aytu BioPharma, Inc. - Common Stock last traded?
The last trade of Aytu BioPharma, Inc. - Common Stock was at 01/02/26 04:00 PM ET
What is the market capitalization of Aytu BioPharma, Inc. - Common Stock?
The market capitalization of Aytu BioPharma, Inc. - Common Stock is 15.42M
How many shares of Aytu BioPharma, Inc. - Common Stock are outstanding?
Aytu BioPharma, Inc. - Common Stock has 15M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap